News & Events :: NeoGenomics, Inc. (NEO)

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

Menu

Test Search

Recent News

Jul 20, 2026 5:23 pm EDT

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

Jul 9, 2026 7:05 am EDT

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

Upcoming Events

Jul 28, 2026 4:30 pm EDT

Second Quarter 2026 Financial Results Conference Call

View All Events

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings